The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $59.72

Today's change-0.85 -1.40%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $59.72

Today's change-0.85 -1.40%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc down (U.S.)$0.85

Abiomed Inc closed lower Friday, dropping (U.S.)$0.85 or 1.40% to (U.S.)$59.72. Shares have lost 5.88% over the last five days, but have gained 56.91% over the last year to date. This security has outperformed the S&P 500 by 152.17% during the last year.

Key company metrics

  • Open(U.S.) $60.50
  • Previous close(U.S.) $60.57
  • High(U.S.) $60.88
  • Low(U.S.) $59.60
  • Bid / Ask-- / --
  • YTD % change+56.91%
  • Volume758,213
  • Average volume (10-day)761,198
  • Average volume (1-month)865,345
  • Average volume (3-month)626,329
  • 52-week range(U.S.) $21.84 to (U.S.) $76.90
  • Beta1.69
  • Trailing P/E23.07×
  • P/E 1 year forward100.27×
  • Forward PEG5.68×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.59
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+49.36%

Based on its net profit margin of 49.36%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.62%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue68625249
Total other revenue--------
Total revenue68625249
Gross profit57524239
Total cost of revenue11101010
Total operating expense55484850
Selling / general / administrative35302932
Research & development10899
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income12144-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12144-1
Income after tax99134-2
Income tax, total-87100
Net income99134-2
Total adjustments to net income--------
Net income before extra. items99134-2
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items99134-2
Inc. avail. to common incl. extra. items99134-2
Diluted net income99134-2
Dilution adjustment------0
Diluted weighted average shares44434240
Diluted EPS excluding extraordinary itemsvalue per share2.240.300.09-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share2.240.300.09-0.04